Jackson Square Partners’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-192,312
Closed -$4.68M 84
2022
Q3
$4.68M Sell
192,312
-42,133
-18% -$1.45M 0.12% 60
2022
Q2
$7.26M Buy
234,445
+44,129
+23% +$1.17M 0.17% 55
2022
Q1
$6.64M Buy
190,316
+90,675
+91% +$3.43M 0.07% 75
2021
Q4
$5.89M Buy
99,641
+17,545
+21% +$1.21M 0.05% 74
2021
Q3
$5.46M Buy
+82,096
New +$5.06M 0.03% 79

Other funds holding CYRX

Jackson Square Partners's CYRX Position: Q4 2022 in Review

Jackson Square Partners sold out of CryoPort (CYRX) in Q4 2022, closing a stake of 192,312 shares — an estimated $4.68M sold.

Jackson Square Partners first reported a position in CYRX in Q3 2021 and held it in 5 quarters. The position peaked at $7.26M in Q2 2022. 171 funds tracked by Wall St. Rank hold CYRX as of Q4 2022.

  • Jackson Square Partners reported no remaining CryoPort position as of Q4 2022 after selling out during the quarter.
  • Jackson Square Partners sold 192,312 CryoPort shares in Q4 2022, an estimated $4.68M.
  • Jackson Square Partners first reported a position in CryoPort in Q3 2021 and held it in 5 quarters.
  • Jackson Square Partners's CryoPort position peaked at $7.26M in Q2 2022.
  • 171 funds tracked by Wall St. Rank held CryoPort as of Q4 2022.

Based on Jackson Square Partners's 13F filing for Q4 2022, filed 9 Feb 2023.